We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.04 | -3.02% | 33.35 | 33.50 | 32.825 | 33.24 | 13,747,891 | 01:00:00 |
From Nov 2021 to Nov 2024
By Kathryn Hardison
GSK PLC has begun shipping doses of its influenza vaccines to U.S. health care providers and pharmacies ahead of the upcoming flu season, and the company said Monday that it expects to distribute over 50 million doses.
The distribution of GSK's quadrivalent influenza vaccine immediately follows a licensing and lot-release approval from the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research, GSK said.
Both FluLaval Quadrivalent and Fluarix Quadrivalent vaccines will be available to patients six months and older, in line with recommendations from the U.S. Centers for Disease Control and Prevention, the company said.
GSK shares edged 0.8% higher to $17.69 Monday, up 10% for the year.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
July 11, 2022 15:57 ET (19:57 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
